|
Variable
|
DM group
|
No DM group
|
P value
|
|---|
|
No. of patients
|
46
|
43
| |
|
Age (years)
|
60.9 ± 11.2
|
61.6 ± 13.2
|
0.758
|
|
Male, N (%)
|
29 (63%)
|
24 (56%)
|
0.487
|
|
Body mass index (kg/m2)
|
24.0 ± 3.2
|
23.8 ± 4.0
|
0.792
|
|
Hypertension, N (%)
|
28 (61%)
|
9 (21%)
|
<0.001*
|
|
Laboratory profiles
|
|
Creatinine (mg/dL)
|
2.4 ± 2.8
|
1.1 ± 0.2
|
0.006†
|
|
eGFR (mL/min/1.73 m2)
|
53.1 ± 31.2
|
70.6 ± 17.0
|
0.002†
|
|
Total cholesterol (mg/dL)
|
167.6 ± 39.2
|
159.6 ± 40.1
|
0.361
|
|
Triglycerides (mg/dL)
|
130.3 ± 78.2
|
140.5 ± 121.9
|
0.874
|
|
HDL cholesterol (mg/dL)
|
45.0 ± 14.3
|
47.3 ± 12.9
|
0.386
|
|
LDL cholesterol (mg/dL)
|
92.7 ± 37.0
|
97.3 ± 23.6
|
0.600
|
|
Medication, N (%)
|
|
Anticoagulants
|
32 (70%)
|
31 (72%)
|
0.793
|
|
β-Blockers
|
26 (57%)
|
23 (53%)
|
0.774
|
|
ACEI/ARB
|
40 (87%)
|
38 (88%)
|
0.839
|
|
CCB
|
1 (2%)
|
2 (5%)
|
0.518
|
|
Diuretics
|
28 (61%)
|
29 (67%)
|
0.518
|
|
Statins
|
15 (33%)
|
6 (14%)
|
0.038*
|
-
ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker, DM diabetes mellitus, eGFR estimated glomerular filtration rate, HDL high-density lipoprotein, LDL low-density lipoprotein
- * P < 0.05 by Chi square test
-
†
P < 0.05 by independent t test or Mann–Whitney test
